Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2575
1.68 %
$ 65.9 M
Market Cap
-0.81
P/E
ADAP - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss ADAP - Adaptimmune Therapeutics plc
-1.9 M
LAST VALUE
-47.44%
2 YEAR CAGR
23.51%
5 YEAR CAGR
-27.27%
10 YEAR CAGR